Selective Kinin Receptor B2 Antagonist Icatibant Reduces SARS-CoV-2 Replication in Primary Bronchial Epithelium Early
Ontology highlight
ABSTRACT: Selective Kinin Receptor B2 Antagonist Icatibant Reduces SARS-CoV-2 Replication in Primary Bronchial Epithelium Early
PROVIDER: PRJNA736080 | ENA |
REPOSITORIES: ENA
ACCESS DATA